Aytatli, A. Et Al. 2022. AZD4547 targets the FGFR/Akt/SOX2 axis to overcome paclitaxel resistance in head and neck cancer. CELLULAR ONCOLOGY , vol.45, no.1 , 41-56.

Aytatli, A., Barlak, N., Sanli, F., Caglar, H. O., GÜNDOĞDU, B., TATAR, A., ... Ittmann, M.(2022). AZD4547 targets the FGFR/Akt/SOX2 axis to overcome paclitaxel resistance in head and neck cancer. CELLULAR ONCOLOGY , vol.45, no.1, 41-56.

Aytatli, Abdulmelik Et Al. "AZD4547 targets the FGFR/Akt/SOX2 axis to overcome paclitaxel resistance in head and neck cancer," CELLULAR ONCOLOGY , vol.45, no.1, 41-56, 2022

Aytatli, Abdulmelik Et Al. "AZD4547 targets the FGFR/Akt/SOX2 axis to overcome paclitaxel resistance in head and neck cancer." CELLULAR ONCOLOGY , vol.45, no.1, pp.41-56, 2022

Aytatli, A. Et Al. (2022) . "AZD4547 targets the FGFR/Akt/SOX2 axis to overcome paclitaxel resistance in head and neck cancer." CELLULAR ONCOLOGY , vol.45, no.1, pp.41-56.

@article{article, author={Abdulmelik Aytatli Et Al. }, title={AZD4547 targets the FGFR/Akt/SOX2 axis to overcome paclitaxel resistance in head and neck cancer}, journal={CELLULAR ONCOLOGY}, year=2022, pages={41-56} }